Wiszniewska, M.; Włodarczyk, U.; Sury, M.; Słomka, A.; Piekuś-Słomka, N.; Żdanowicz, A.; Żekanowska, E.
The Usefulness of Factor XIII Concentration Assessment in Patients in the Acute Phase of Ischaemic Stroke Treated with Thrombolysis. Neurol. Int. 2024, 16, 551-560.
https://doi.org/10.3390/neurolint16030041
AMA Style
Wiszniewska M, Włodarczyk U, Sury M, Słomka A, Piekuś-Słomka N, Żdanowicz A, Żekanowska E.
The Usefulness of Factor XIII Concentration Assessment in Patients in the Acute Phase of Ischaemic Stroke Treated with Thrombolysis. Neurology International. 2024; 16(3):551-560.
https://doi.org/10.3390/neurolint16030041
Chicago/Turabian Style
Wiszniewska, Małgorzata, Urszula Włodarczyk, Magdalena Sury, Artur Słomka, Natalia Piekuś-Słomka, Anna Żdanowicz, and Ewa Żekanowska.
2024. "The Usefulness of Factor XIII Concentration Assessment in Patients in the Acute Phase of Ischaemic Stroke Treated with Thrombolysis" Neurology International 16, no. 3: 551-560.
https://doi.org/10.3390/neurolint16030041
APA Style
Wiszniewska, M., Włodarczyk, U., Sury, M., Słomka, A., Piekuś-Słomka, N., Żdanowicz, A., & Żekanowska, E.
(2024). The Usefulness of Factor XIII Concentration Assessment in Patients in the Acute Phase of Ischaemic Stroke Treated with Thrombolysis. Neurology International, 16(3), 551-560.
https://doi.org/10.3390/neurolint16030041
